Revolutionizing Infection Treatment: Cutting-Edge Approaches in Antimicrobial Stewardship

Dear Colleagues,

The global burden of antimicrobial resistance (AMR) is one of the most pressing public health challenges of the 21st century. To prevent further AMR, it is imperative that gaps in knowledge and clinical practice be resolved via cutting-edge clinical strategies, evidence-based tools, and multidisciplinary approaches that optimize antimicrobial therapy.

The aim of this Special Issue is to explore and promote innovative antimicrobial stewardship interventions that enhance the treatment of infections across diverse healthcare settings. This Special Issue seeks to highlight innovative strategies, technologies, and evidence-based practices that improve clinical outcomes, reduce AMR, and ensure the sustainability of effective infection management.

This Special Issue welcomes topics inlcuding innovative diagnostic tools for infection identification and treatment, strategies for personalized antimicrobial therapy, integration of technology and artificial intelligence in antimicrobial stewardship programs, clinical advancements in antimicrobial stewardship in low-resource environments, and advancements in antimicrobial stewardship in outpatient and community-based settings. Contributions are encouraged from diverse disciplines, not limited to microbiology, pharmacology, epidemiology, public health, and clinical medicine to provide a multidisciplinary perspective regarding treatment optimization. Additionally, original research articles and reviews are welcome and encouraged.

We look forward to receiving your contributions.

Dr. Jacob Myles Keck
Dr. Aleksandra Barac
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.